This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page.(September 2017) (Learn how and when to remove this message)
This article contains content that is written like an advertisement. Please help improve it by removing promotional content and inappropriate external links, and by adding encyclopedic content written from a neutral point of view.(September 2017) (Learn how and when to remove this message)
This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (November 2017)
This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (September 2017)
(Learn how and when to remove this message)
Perry Nisen
Born
July 27, 1955
New York, NY
Nationality
American
Alma mater
Stanford, Albert Einstein College of Medicine
Known for
Cancer drug discovery and development, clinical trial data sharing, deletions by transposons, X-recessive disorders in females, molecular genetics of human cancers
Scientific career
Fields
Molecular Biology, Clinical Translation, Drug Discovery and Development, Clinical Data Sharing, Executive Management, Governance
Institutions
Sanford Burnham Prebys Medical Discovery Institute GlaxoSmithKline, Abbott Laboratories
Thesis
Flexible Genomes: Observations on the Rearrangement of DNA Sequences
Doctoral advisor
Stanley Norman Cohen (pre-doctoral), Lucy Shapiro(doctoral)
Perry Nisen is an American physician and the former chief executive officer (CEO) of the Sanford Burnham Prebys Medical Discovery Institute (SBP).[1] He was appointed as CEO in August 2014, and held the Donald Bren Chief Executive Chair.[2]
^"Sanford Burnham Prebys CEO Perry Nisen Retiring in September". Times of San Diego. 2017-08-10.
^"Meet Sanford-Burnham's new CEO Perry Nisen". San Diego Union Tribune. 19 August 2014.
PerryNisen is an American physician and the former chief executive officer (CEO) of the Sanford Burnham Prebys Medical Discovery Institute (SBP). He...
August 8, 2020. Retrieved September 23, 2020. Giang, Vivian; Guey, Lynne; Nisen, Max (May 16, 2013). "16 Wildly Successful People Who Majored In English"...
Whisky: The Product and The Industry. W. F. Rannie. ISBN 9780919953147. Nisen, Max (October 15, 2014). "All Hail King Whiskey". The Atlantic. Retrieved...
Global Information
